Focusing on a specific subgroup of renal allograft recipients who developed de novo donor-specific antibodies ( dn DSA), a highly significant 6% increase in the risk of post- dn DSA graft loss was calculated for each 1 mL/min/1.73 m 2 decease in eGFR at 3 years postsubclinical dn DSA onset [ 23 ].
← all excerpts
Determinants of the intercept and slope of glomerular filtration rate in recipients of a live donor kidney transplant.
1
—
—